STOCK TITAN

National Healthcare Corp (NHC) senior VP sells shares and details option holdings

(Moderate)
(Negative)
Form Type
4

Rhea-AI Filing Summary

National Healthcare Corp senior vice president sells shares and reports option holdings. Sr. VP of Operations Timothy J. Shelly reported an open-market sale of 1,853 shares of National Healthcare Corp common stock at an average price of $197.2176 per share, leaving him with 1,294 directly held shares.

He also reported several outstanding stock option awards on common stock, including options covering 14,000 shares at an exercise price of $157.13 expiring in 2031, 7,333 shares at $90.62 expiring in 2030, 5,333 shares at $94.10 expiring in 2029, and 2,400 shares at $53.94 expiring in 2028.

Positive

  • None.

Negative

  • None.

Insights

Senior VP makes a modest stock sale while retaining sizable options.

Sr. VP of Operations Timothy J. Shelly executed an open-market sale of 1,853 shares of National Healthcare Corp common stock at $197.2176 per share, leaving him with 1,294 directly held shares. This is a straightforward disposition of existing equity.

The filing also lists multiple outstanding stock option awards on common stock: 14,000 underlying shares at an exercise price of $157.13 expiring in 2031, 7,333 at $90.62 expiring in 2030, 5,333 at $94.10 expiring in 2029, and 2,400 at $53.94 expiring in 2028. No new grants or exercises are reported; these entries summarize his remaining derivative position.

Given the absence of option exercises or large-scale sales relative to overall company equity, this appears to be a routine insider transaction rather than a thesis-changing event. Future company filings may update how these option positions evolve as they approach their respective expiration dates.

Insider Shelly Timothy J.
Role Sr.VP Operations
Sold 1,853 shs ($365K)
Type Security Shares Price Value
Sale Common Stock 1,853 $197.2176 $365K
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
Holdings After Transaction: Common Stock — 1,294 shares (Direct); Option to Purchase Common Stock — 29,066 shares (Direct)
Shares sold 1,853 shares Open-market sale of common stock
Sale price $197.2176 per share Average price for 1,853 shares sold
Shares held after sale 1,294 shares Direct common stock ownership post-transaction
Option grant 1 14,000 shares at $157.13 Option to purchase common stock, expires 2031-02-23
Option grant 2 7,333 shares at $90.62 Option to purchase common stock, expires 2030-02-24
Option grant 3 5,333 shares at $94.10 Option to purchase common stock, expires 2029-03-05
Option grant 4 2,400 shares at $53.94 Option to purchase common stock, expires 2028-03-08
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Option to Purchase Common Stock financial
""security_title": "Option to Purchase Common Stock""
exercise price financial
""conversion_or_exercise_price": "157.1300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
underlying security financial
""underlying_security_title": "Common Stock""

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did NHC executive Timothy J. Shelly report on this Form 4?

Timothy J. Shelly reported an open-market sale of 1,853 shares of National Healthcare Corp common stock at an average price of $197.2176 per share. After this transaction, he directly holds 1,294 common shares, according to the Form 4 disclosure.

What is Timothy J. Shelly’s role at National Healthcare Corp (NHC)?

Timothy J. Shelly is the Senior Vice President of Operations at National Healthcare Corp. His Form 4 filing reflects his status as an officer of the company and discloses both his common stock holdings and his outstanding stock option awards.

How many National Healthcare Corp (NHC) shares does Timothy J. Shelly hold after the sale?

Following the reported sale, Timothy J. Shelly directly owns 1,294 shares of National Healthcare Corp common stock. This figure represents his remaining direct non-derivative holdings as of the transaction date disclosed in the Form 4.

What stock options on NHC common stock does Timothy J. Shelly currently hold?

The Form 4 shows several option awards: options over 14,000 shares at $157.13 expiring in 2031, 7,333 shares at $90.62 expiring in 2030, 5,333 shares at $94.10 expiring in 2029, and 2,400 shares at $53.94 expiring in 2028.

Did Timothy J. Shelly exercise any stock options in this NHC Form 4 filing?

No option exercises are reported in this filing. The derivative entries list existing option holdings, including exercise prices and expiration dates, but the transaction summary shows zero option exercises and only one open-market sale of common stock.

Is the Form 4 transaction for NHC labeled as a buy or sell by the insider?

The main non-derivative transaction is labeled as an open-market sale with transaction code “S.” It covers 1,853 shares of National Healthcare Corp common stock and is classified as a sell-side transaction in the filing’s transaction summary.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shelly Timothy J.

(Last)(First)(Middle)
100 VINE STREET

(Street)
MURFREESBORO TENNESSEE 37130

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Sr.VP Operations
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/19/2026S1,853D$197.21761,294D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock$53.9403/08/202403/08/2028Common Stock2,4002,400D
Option to Purchase Common Stock$94.103/05/202503/05/2029Common Stock5,3335,333D
Option to Purchase Common Stock$90.6202/24/202602/24/2030Common Stock7,3337,333D
Option to Purchase Common Stock$157.1302/23/202702/23/2031Common Stock14,00014,000D
Explanation of Responses:
/s/ Timothy J. Shelly05/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)